Back to search
FDAFDA · Food and drugs·Recall number D-0512-2026

DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 1.5% DEX. LM/LC, 2L 5PK, Part Number 054-20221, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451.

Published May 13, 2026 · Recall initiated: April 6, 2026

Summary

FDA records drug Class II recall D-0512-2026, published May 13, 2026 and initiated April 6, 2026. Recalling firm: Fresenius Medical Care Holdings, Inc.; Status: Ongoing; Reported quantity: 37,215 bags; Lot: Lot #: 25CU02007, 25CU02008, 25CU02009. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Medical Care Holdings, Inc.
Distributor
Nationwide in the USA
Lot
Lot #: 25CU02007, 25CU02008, 25CU02009
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 1.5% DEX. LM/LC, 2L 5PK, Part Number 054-20221, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451. recalled?

Yes. FDA published recall D-0512-2026 on May 13, 2026. Reported hazard: Lack of Assurance of Sterility: Potential leaks from perforations in bags.

What should I do if I have this product?

Voluntary: Firm initiated · Letter